CONCORD, Mass.--(BUSINESS WIRE)--Coastal Lab Partners, a CLIA and CAP Accredited laboratory in the U.S. with a focus in pharmacogenomics testing, is excited to announce the strategic partnership with inFocus Healthcare Consultants based in Charleston, SC to exclusively lead the Commercial Sales Organization, effective immediately. These organizational changes are designed to capitalize on Coastal Lab Partners strong sales momentum, as well as to propel the organization to new heights in 2018 and beyond.
“inFocus Healthcare has a top-notch contract sales organization in place, as demonstrated by prior years’ stellar performance in the biotech and medical device sector,” said Robert Bickford, CEO, Coastal Lab Partners, “and I am thrilled to welcome both Josh Lambert and Daniel Raykes, Managing Partners of inFocus Healthcare to the team along with Josh Samek, Director of Commercial Operations. With these new additions, as well as the exciting launch of GenetiCision™ and expansion of our prescription decision analytics that helps our clients identify who within their patient population can benefit from pharmacogenetic testing, Coastal Lab partners is poised to deliver significant growth as we continue to champion pharmacogenomics that delivers exceptional results.”
About Coastal Lab Partners
We believe patient care can be enhanced through the appropriate application of pharmacogenomic testing. We embrace the continual advances in pharmacogenomics research and we put this research to work for clinicians and patients every day.
Our mission, as a clinical laboratory and leader in precision medication management, is to help our clients apply the best practices of precision medicine in ways that make sense for their patient population. Coastal Lab Partners utilizes the most advanced equipment, tools, software, storage available to bring our customers the most advanced, accurate pharmacogenomic information. We do all of this in a secure HIPAA compliant environment. For more information, visit www.coastalpgx.com.
